TRACON PHARMACEUTICALS INC's ticker is TCON and the CUSIP is 89237H209. A total of 28 filers reported holding TRACON PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $4 | – | 14 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Opaleye Management Inc. | 2,518,371 | $29,465,000 | 3.85% |
Ikarian Capital, LLC | 2,716,840 | $31,787,000 | 1.40% |
Telemetry Investments, L.L.C. | 10,223 | $120,000 | 0.20% |
Vigilare Wealth Management | 14,000 | $164,000 | 0.16% |
BOOTHBAY FUND MANAGEMENT, LLC | 294,031 | $3,440,000 | 0.13% |
Johnson & Johnson Innovation - JJDC, Inc. | 84,003 | $983,000 | 0.13% |
NEA Management Company, LLC | 346,718 | $4,057,000 | 0.11% |
GSA CAPITAL PARTNERS LLP | 46,375 | $543,000 | 0.09% |
683 Capital Management, LLC | 75,000 | $878,000 | 0.04% |
MGO ONE SEVEN LLC | 16,000 | $187,000 | 0.04% |